Back
Innate Pharma SA Stock Price Chart
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
50
IPHA
Innate Pharma SA
Last Price:
$1.90
Seasonality Move:
12.9%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is relatively stagnant and IPHA is experiencing slight selling pressure.
Innate Pharma SA Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.9 | Buy |
| 20-day SMA: | 1.89 | Buy |
| 50-day SMA: | 1.97 | Sell |
| 200-day SMA: | 2.02 | Sell |
| 8-day EMA: | 1.9 | Buy |
| 20-day EMA: | 1.91 | Buy |
| 50-day EMA: | 1.9 | Buy |
| 200-day EMA: | 1.19 | Buy |
Innate Pharma SA Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 49.42 | Sell |
| Chaikin Money Flow: | -1163 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.77 - 2.01) | Buy |
| Bollinger Bands (100): | (1.87 - 2.17) | Sell |
Innate Pharma SA Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Innate Pharma SA Stock
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 1.91 while IPHA 8-day simple moving average is 1.90, which is a Buy signal.
-
The stock price of IPHA is 1.91 while Innate Pharma SA 20-day SMA is 1.89, which makes it a Buy.
-
Innate Pharma SA 50-day simple moving average is 1.97 while IPHA share price is 1.91, making it a Sell technically.
-
IPHA stock price is 1.91 and Innate Pharma SA 200-day simple moving average is 2.02, creating a Sell signal.
IPHA Technical Analysis vs Fundamental Analysis
Sell
50
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a SellThe current Innate Pharma SA [IPHA] share price is $1.91. The Score for IPHA is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Innate Pharma SA Stock Info
Market Cap:
176.1M
Price in USD:
1.91
Share Volume:
3.5K
Innate Pharma SA 52-Week Range
52-Week High:
3.51
52-Week Low:
1.43
Sell
50
Innate Pharma SA (IPHA)
is a Sell
Innate Pharma SA Share Price Forecast
-
What is the Innate Pharma SA stock price today?The Innate Pharma SA stock price is 1.91 USD today.
-
Will IPHA stock go up or go down?Innate Pharma SA> share price is forecast to RISE/FALL based on technical indicators
-
Is Innate Pharma SA overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innate Pharma SA is overvalued.
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 1.91 while IPHA 8-day exponential moving average is 1.90, which is a Buy signal.
-
The stock price of IPHA is 1.91 while Innate Pharma SA 20-day EMA is 1.91, which makes it a Buy.
-
Innate Pharma SA 50-day exponential moving average is 1.90 while IPHA share price is 1.91, making it a Buy technically.
-
IPHA stock price is 1.91 and Innate Pharma SA 200-day simple moving average is 1.19, creating a Buy signal.
Fundamental Analysis of Innate Pharma SA
Is Innate Pharma SA a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.04 per share.
Technical Analysis of Innate Pharma SA
Should I short Innate Pharma SA stock?
-
IPHA Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Innate Pharma SA is a Sell
-
Innate Pharma SA Relative Strength Index (RSI) is 49.42, which suggest Innate Pharma SA is oversold
-
The Bollinger Bands (25) for Innate Pharma SA is (1.77 - 2.01), which suggest Innate Pharma SA is a Sell
-
The Bollinger Bands (100) for Innate Pharma SA is (1.87 - 2.17), which suggest Innate Pharma SA is a Sell
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.